WHO, Central Asia and Russia discuss the use of drugs against coronavirus

WHO, Central Asia and Russia discuss the use of drugs against coronavirus

Representatives of the World Health Organization, ministers of health of the Cen-tral Asian states and Russia by video link discussed the issues of counteracting the spread of coronavirus. This was reported by the Uzbek Ministry of Health.

The discussion was attended by WHO Regional Director Hans Kluge and minis-ters of health of Turkmenistan, Kazakhstan, Kyrgyzstan, Tajikistan, Russia and Uzbekistan.

They discussed the current epidemiological situation in the region, and also touched on the use of experimental and licensed drugs in the treatment of patients with COVID-19.

The parties during the dialogue emphasized that in the situation of the corona-virus pandemic, it is important to work together to exchange experiences and up-dates, to learn from each other, so that the world can develop the widest possible set of measures to combat this virus in various conditions.

The situation with coronavirus in Central Asia is mixed. Of the five countries in three countries of the region (Kazakhstan, Kyrgyzstan and Uzbekistan), cases of infection have been recorded, and a large-scale fight against COVID-19 infection is ongoing.

No cases of coronavirus infection have been reported in Turkmenistan and Tajik-istan. Since the vaccine against COVID-19 is only being developed, but the use of previously known drugs or their combination yielded good results, Turkmeni-stan is increasing its supply of such medicines and disinfectants.

As previously reported by ORIENT, Ashgabat purchased in Russia a direct-acting antiviral drug, Triazavirin from the family of azoloazines, which is effective against 15 types of influenza. Experts believe that it can be effective against COVID-19.